Literature DB >> 7874268

Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.

H Saito1, S Tada, H Ebinuma, S Tsunematsu, T Kagawa, N Kumagai, Y Inagaki, T Watanabe, K Tsuchimoto, T Morizane.   

Abstract

We have previously reported the effect of a differentiation inducer, sodium butyrate (SB), on human hepatocellular carcinoma (HCC) cell lines, demonstrating that it was a potent inducer of differentiation. In the present study, we investigated the alteration in expression of an antigen defined by a murine monoclonal antibody, H2, as well as alterations in the expression of other antigens, on the HCC cell lines HCC-T, HCC-M, and PLC/PRF/5, since it is known that specific antigenic changes occur during the differentiation of leukemic cells. The expression of the antigen defined by H2 increased immunocytochemically on HCC-T, HCC-M, and PLC/PRF/5 during treatment with SB. A flowcytometric study showed that almost all the HCC-T and HCC-M cells treated with SB highly expressed this antigen after 5 days' treatment. The antigen expression detected by H2 decreased after the removal of SB from the medium. On the other hand, antigen expression detected by another monoclonal antibody, 5C11, was not changed by this treatment. The expression of intracellular adhesion molecule (ICAM)-1 in HCC-T increased slightly, but that of beta 2-microglobulin and HLA-DR did not change. These results demonstrated that some antigen expression was changed by SB treatment and that the antigen defined by H2 seemed to be highly expressed on human HCC cells in the differentiated state.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874268     DOI: 10.1007/bf02349279

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  22 in total

1.  Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.

Authors:  T D Mullins; H F Kern; R S Metzgar
Journal:  Pancreas       Date:  1991-09       Impact factor: 3.327

2.  [Characterization of human liver-specific antigen 1 (HLSA1) defined by the murine monoclonal antibody H2].

Authors:  H Saito; T Morizane; A Iino; K Tsuchimoto; Y Hamada; I Satoh; K Sawaguchi; Y Inagaki; T Watanabe; M Tsuchiya
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-03

Review 3.  Bioactive gangliosides: differentiation inducers for hematopoietic cells and their mechanism(s) of actions.

Authors:  M Saito
Journal:  Adv Lipid Res       Date:  1993

4.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

5.  Transforming growth factor beta 1 differentially regulates alpha-fetoprotein and albumin in HuH-7 human hepatoma cells.

Authors:  K Nakao; K Nakata; S Mitsuoka; A Ohtsuru; A Ido; M Hatano; Y Sato; T Nakayama; M Shima; Y Kusumoto
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

6.  Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.

Authors:  H Nojiri; F Takaku; M Ohta; Y Miura; M Saito
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60.

Authors:  H Nojiri; F Takaku; T Tetsuka; K Motoyoshi; Y Miura; M Saito
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

8.  Neolacto-series gangliosides induce granulocytic differentiation of human promyelocytic leukemia cell line HL-60.

Authors:  H Nojiri; S Kitagawa; M Nakamura; K Kirito; Y Enomoto; M Saito
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

9.  A monoclonal antibody specifically reactive with Ewing's sarcoma.

Authors:  S Hara; E Ishii; S Tanaka; J Yokoyama; K Katsumata; J Fujimoto; J Hata
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

10.  Changes of proliferative activity and phenotypes in spontaneous differentiation of a colon cancer cell line.

Authors:  A Hara; T Hibi; M Yoshioka; K Toda; N Watanabe; A Hayashi; Y Iwao; H Saito; T Watanabe; M Tsuchiya
Journal:  Jpn J Cancer Res       Date:  1993-06
View more
  5 in total

1.  Effects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cells.

Authors:  Masaki Kitazono; Hiroyuki Shinchi; Sumiya Ishigami; Shinichi Ueno; Shoji Natsugoe
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

2.  Dual effects of sodium butyrate on hepatocellular carcinoma cells.

Authors:  Wenjun Jiang; Qiya Guo; Jun Wu; Bin Guo; Yingming Wang; Shenan Zhao; Huiling Lou; Xin Yu; Xinyu Mei; Chaoqun Wu; Shouyi Qiao; Yanhua Wu
Journal:  Mol Biol Rep       Date:  2012-01-07       Impact factor: 2.316

3.  Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha.

Authors:  T Masuda; H Saito; F Kaneko; K Atsukawa; M Morita; H Inagaki; N Kumagai; K Tsuchimoto; A H Ishii
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

4.  Antibody-dependent cell-mediated cytotoxicity against cell lines generated by liver-specific idiotype-bearing antibody.

Authors:  T Kagawa; H Saito; T Morizane; K Tsuchimoto; Y Inagaki; K Sawaguchi; N Iwabuchi; N Kumagai; M Tsuchiya; H Ishii
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

5.  Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression.

Authors:  Libin Wei; Yuanyuan Dai; Yuxin Zhou; Zihao He; Jingyue Yao; Li Zhao; Qinglong Guo; Lin Yang
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.